Pfizer vaccine
UK probing if allergic reactions linked to Pfizer vaccine
British regulators warned Wednesday that people who have a history of serious allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination program.
EXPLAINER: Final steps in US review of COVID-19 vaccine
Pfizer’s COVID-19 vaccine is entering the final phase of review before the US government decides whether to allow millions to get the shots.
US regulators post positive review of Pfizer vaccine data
Documents released by U.S. regulators Tuesday confirmed that Pfizer and BioNTech’s COVID-19 vaccine was strongly protective against COVID-19 -- offering the world’s first detailed look at the evidence behind the shots.
China prepares large-scale rollout of COVID-19 vaccines
Provincial governments across China are placing orders for experimental, domestically made coronavirus vaccines, though health officials have yet to say how well they work or how they may reach the country’s 1.4 billion people.
States plan for vaccines as daily US virus deaths top 3,100
States drafted plans Thursday for who will go to the front of the line when the first doses of COVID-19 vaccine become available later this month, as U.S. deaths from the outbreak eclipsed 3,100 in a single day, obliterating the record set last spring.
UK authorizes Pfizer vaccine for emergency use
Pfizer and BioNTech say they've won permission Wednesday for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic.